| ERNST | European Resuscitation Nimodipine Study |
|---|
| Nim | Nimodipine |
|---|
| nimodipine | <chemical> A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects, lowers blood pressure, and is effective in the therapy and/or prevention of cerebral vasospasm caused by stroke, cerebral haemorrhage, aneurysm, severe head injury, or cerebral ischemia. Pharmacological action: antihypertensive agents, calcium channel blockers, vasodilator agents. Chemical name: 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 1-methylethyl ester (12 Dec 1998) |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
º¸·É´Ï¸ðµðÇÉÁÖ10mg - »õâ
|
º¸·ÉÁ¦¾à |
A09303261 | Nimodipine | Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|